Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects
- PMID: 11735095
- DOI: 10.1053/meta.2001.28079
Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects
Abstract
Hyperhomocysteinemia (HHcy) is a metabolic disorder frequently occurring in the elderly population. Recently several reports have suggested abnormalities in homocysteine (tHcy) metabolism implicating HHcy as a metabolic link in the multifactorial processes characterizing many geriatric illnesses-with special emphasis on atherosclerotic vascular diseases and cognitive impairment. The present study was undertaken in a large sample of elderly hospitalized subjects to determine (1) the prevalence of HHcy, (2) the association of HHcy with vascular and cognitive disorders, and (3) the factors independently predicting Hhcy. Six hundred elderly subjects (264 men and 336 women; mean age, 79 +/- 9 years) were randomly chosen from those admitted as inpatients over a period of 3 years. In all patients, body mass index (BMI), mid-upper arm muscle area (MUAMA), plasma cholesterol, triglycerides, total proteins, albumin, lymphocyte count, creatinine, homocysteine (fasting and 4 hours after methionine oral load), serum vitamin B(6), vitamin B(12), and folate concentrations were measured. The presence of disease or use of medications known to affect homocysteine plasma levels were also recorded. The mean fasting tHcy level was 16.8 +/- 12 micromol/L in the whole sample, 18.18 +/- 13.25 micromol/L in men, and 15.86 +/- 12.14 micromol/L in women (P =.005 men v women). The mean Hcy level 4 hours after methionine load was 37.95 +/- 20.9 in the whole sample. Prevalence of hyperhomocysteinemia (fasting Hcy > or = 15 micromol/L or 4 hours after methionine load > or = 35 micromol/L) was 61% (365/600) (67% in men and 56% in women, P <.05). HHcy was rarely (8%) an isolated disorder; in addition to diabetes (20%), renal failure (48.2%), and malnutrition (20.2%), it was often associated with heart failure (30%), malignancies (20.5%), and the use of diuretics (56%) and anticonvulsant drugs (13%). Plasma homocysteine progressively increases across subjects from those with no diabetes, malnutrition, renal failure, obesity, inflammatory bowel disease, heart failure to those with 1, 2, or more concurrent diseases. Multiple stepwise regression analysis showed that 72% of plasma total fasting tHcy variability was explained by age, serum folate, plasma albumin, use of diuretics, and renal function (measured as plasma creatinine clearance). In conclusion, the present study documents that hyperhomocysteinemia, in elderly hospitalized patients is (1) a common finding, (2) frequently associated with vascular and cognitive disorders, and (3) probably a secondary phenomenon in most cases. The major predictor of high plasma homocysteine levels were age, serum folate, plasma albumin, plasma creatinine clearance, and use of diuretic drugs. These variables explain a large proportion of plasma Hcy variability.
Copyright 2001 by W.B. Saunders Company
Similar articles
-
Homocysteine and its determinants in nondialyzed chronic kidney disease patients.J Am Diet Assoc. 2006 Feb;106(2):267-70. doi: 10.1016/j.jada.2005.10.035. J Am Diet Assoc. 2006. PMID: 16442876
-
Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.Exp Clin Endocrinol Diabetes. 2004 Jan;112(1):44-51. doi: 10.1055/s-2004-815726. Exp Clin Endocrinol Diabetes. 2004. PMID: 14758571
-
Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.J Clin Gastroenterol. 2008 May-Jun;42(5):481-6. doi: 10.1097/MCG.0b013e318046eab0. J Clin Gastroenterol. 2008. PMID: 18344891
-
Hyperhomocysteinemia: a new risk factor for degenerative diseases.Clin Lab. 2002;48(9-10):471-81. Clin Lab. 2002. PMID: 12389706 Review.
-
Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.Z Kardiol. 2004 Jun;93(6):439-53. doi: 10.1007/s00392-004-0075-3. Z Kardiol. 2004. PMID: 15252738 Review.
Cited by
-
Homocysteine and cognitive function in elderly people.CMAJ. 2004 Oct 12;171(8):897-904. doi: 10.1503/cmaj.1031586. CMAJ. 2004. PMID: 15477631 Free PMC article. Review.
-
Elevated Serum Homocysteine Levels Have Differential Gender-Specific Associations with Motor and Cognitive States in Parkinson's Disease.Parkinsons Dis. 2019 May 29;2019:3124295. doi: 10.1155/2019/3124295. eCollection 2019. Parkinsons Dis. 2019. PMID: 31275543 Free PMC article.
-
Vitamin Status and the Development of Postoperative Cognitive Decline in Elderly Surgical Oncologic Patients.Ann Surg Oncol. 2018 Jan;25(1):231-238. doi: 10.1245/s10434-017-6118-6. Epub 2017 Oct 20. Ann Surg Oncol. 2018. PMID: 29058145 Free PMC article.
-
Total serum homocysteine levels do not identify cognitive dysfunction in multimorbid elderly patients.J Nutr Health Aging. 2009 Feb;13(2):121-6. doi: 10.1007/s12603-009-0018-9. J Nutr Health Aging. 2009. PMID: 19214340
-
Systemic risk factors correlated with hyperhomocysteinemia for specific MTHFR C677T genotypes and sex in the Chinese population.Ann Transl Med. 2020 Nov;8(21):1455. doi: 10.21037/atm-20-6587. Ann Transl Med. 2020. PMID: 33313200 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical